Biotechnology company Genzyme (GENZ) and billionaire investor Carl Icahn have reached a settlement in their proxy fight, the company said on Wednesday – Reuters
Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!
Leave a Reply